India to Thailand: Hydroxychloroquine Export Trade Route
India has recorded 34 verified shipments of Hydroxychloroquine exported to Thailand, representing a combined trade value of $2.1M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $60.8K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED , which accounts for 41% of total export value with 7 shipments worth $840.1K USD. On the buying side, RANBAXY (THAILAND) CO., LTD. is the largest importer in Thailand with $788.2K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 74% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Thailand Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $2.1M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED , which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $60.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with hydroxychloroquine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 13.1%, placing it at rank #10 among India's top hydroxychloroquine export destinations globally.
On the import side, key buyers of Indian hydroxychloroquine in Thailand include RANBAXY (THAILAND) CO., LTD. , KASPA PHARMACEUTICAL (THAILAND), KASPA PHARMACEUTICAL THAILAND and 11 others. RANBAXY (THAILAND) CO., LTD. is the single largest importer with 6 shipments valued at $788.2K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ2
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#10
- Annual growth+13.1%
- Demand growth+11.6%
- Regulatory ease77/100
Top 10 Indian Hydroxychloroquine Exporters to Thailand
Showing top 10 of 7 Indian suppliers exporting Hydroxychloroquine to Thailand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $120.0K per shipment | 7 | $840.1K | 40.7% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $60.4K per shipment | 7 | $423.1K | 20.5% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $39.0K per shipment | 7 | $273.0K | 13.2% |
| 4 | CADILA HEALTHCARE LIMITED Avg $47.4K per shipment | 5 | $237.1K | 11.5% |
| 5 | ZYDUS LIFESCIENCES LIMITED Avg $37.1K per shipment | 5 | $185.3K | 9.0% |
| 6 | CADILA HEALTHCARE LTD Avg $44.3K per shipment | 2 | $88.6K | 4.3% |
| 7 | KOPRAN LIMITED Avg $18.3K per shipment | 1 | $18.3K | 0.9% |
This table shows the top 10 of 7 Indian companies exporting hydroxychloroquine to Thailand, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED , CADILA HEALTHCARE LTD, KOPRAN LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 7 shipments worth $840.1K USD, giving it a 41% market share. The top 3 suppliers together account for 74% of the total trade value on this route.
Top 10 Hydroxychloroquine Importers in Thailand
Showing top 10 of 14 known buyers in Thailand receiving Hydroxychloroquine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian hydroxychloroquine in Thailand include RANBAXY (THAILAND) CO., LTD. , KASPA PHARMACEUTICAL (THAILAND), KASPA PHARMACEUTICAL THAILAND, RANBAXY (THAILAND) CO., LTD., RANBAXY THAILAND CO LIMITED, among 14 total buyers. The largest importer is RANBAXY (THAILAND) CO., LTD. , accounting for $788.2K USD across 6 shipments — representing 38% of all hydroxychloroquine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RANBAXY (THAILAND) CO., LTD. | 6 | $788.2K | 38.2% |
| 2 | KASPA PHARMACEUTICAL (THAILAND) | 5 | $222.3K | 10.8% |
| 3 | KASPA PHARMACEUTICAL THAILAND | 4 | $208.0K | 10.1% |
| 4 | RANBAXY (THAILAND) CO., LTD. | 2 | $172.0K | 8.3% |
| 5 | RANBAXY THAILAND CO LIMITED | 3 | $152.7K | 7.4% |
| 6 | KASPA PHARMACEUTICAL (THAILAND) | 3 | $116.1K | 5.6% |
| 7 | KASPA PHARMACEUTICAL THAILAND CO LTD | 2 | $88.6K | 4.3% |
| 8 | KASPA PHARMACEUTICAL (THAILAND) CO. | 2 | $69.1K | 3.3% |
| 9 | RANBAXY THAILAND CO LTD | 1 | $59.6K | 2.9% |
| 10 | RANBAXY (THAILAND) CO., LTD | 1 | $51.9K | 2.5% |
Showing top 10 of 14 Hydroxychloroquine importers in Thailand on this route.
Top 10 Hydroxychloroquine Formulations Imported by Thailand
Showing top 10 of 16 product formulations shipped on the India to Thailand Hydroxychloroquine route, ranked by trade value
Thailand imports a wide range of hydroxychloroquine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HYDROQUIN TABLETS (HYDROXYCHLOROQUINE) ( — accounts for $955.0K USD across 8 shipments. There are 16 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HYDROQUIN TABLETS (HYDROXYCHLOROQUINE) ( | 8 | $955.0K | 46.2% |
| 2 | ZYQUENIL HYDROXYCHLOROQUINE SULFATE TAB | 4 | $177.9K | 8.6% |
| 3 | ZYQUENIL (HYDROXYCHLOROQUINE SULFATE TABS USP 200MG) 10X10 T | 4 | $160.6K | 7.8% |
| 4 | ZYQUENIL (HYDROXYCHLOROQUINE SULFATE TAB | 3 | $99.5K | 4.8% |
| 5 | ZYQUENIL HYDROXYCHLOROQUINE SULFATE TABS USP 200MG 10 X 10T | 2 | $88.6K | 4.3% |
| 6 | HYDROQUIN TABLETS HYDROXYCHLOROQUINE | 2 | $78.3K | 3.8% |
| 7 | HYDROQUIN TABLETS HYDROXYCHLOROQUINEPACK:BOX5X10s BATCH:SLE0305ASLE0385A | 1 | $74.4K | 3.6% |
| 8 | HYDROQUIN TABLETS HYDROXYCHLOROQUINE PACK Box05x10s | 1 | $59.6K | 2.9% |
| 9 | ZYQUENIL(HYDROXYCHLOROQUINE SULFATE TABSUSP 200MG 10X10)(10 X 10 T) | 1 | $59.3K | 2.9% |
| 10 | ZYQUENIL HYDROXYCHLOROQUINE SULFATE TABS USP 200MG 10 X 10 T | 1 | $59.2K | 2.9% |
Showing top 10 of 16 Hydroxychloroquine formulations imported by Thailand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 11 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's hydroxychloroquine exports to Thailand are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 74% of total trade value on this route. The average shipment value of $60.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as zyquenil hydroxychloroquine sulfate tab and zyquenil (hydroxychloroquine sulfate tabs usp 200mg) 10x10 t, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, RANBAXY (THAILAND) CO., LTD. is the largest importer with 6 shipments worth $788.2K USD — representing 38% of all hydroxychloroquine imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.1M
- Avg. Shipment
- $60.8K
- Suppliers
- 7
- Buyers
- 14
- Transit (Sea)
- ~31 days
- Annual Growth
- +13.1%
Related Analysis
Reverse Direction
Thailand → India — Hydroxychloroquine (Import)Other Hydroxychloroquine Routes
Unlock the Full India to Thailand Hydroxychloroquine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 34 shipments on this route.
Frequently Asked Questions — India to Thailand Hydroxychloroquine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Hydroxychloroquine to Thailand?
The leading Indian exporters of Hydroxychloroquine to Thailand are SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 41% of total trade value on this route.
Q What is the total value of Hydroxychloroquine exports from India to Thailand?
India exports Hydroxychloroquine to Thailand worth approximately $2.1M USD across 34 recorded shipments. The average value per shipment is $60.8K USD.
Q Which ports does India use to ship Hydroxychloroquine to Thailand?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 11 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Thailand for Hydroxychloroquine?
The average transit time for Hydroxychloroquine shipments from India to Thailand is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Thailand Hydroxychloroquine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.1% with demand growth tracking at 11.6%. The route is ranked #10 among India's top Hydroxychloroquine export destinations globally.
Q How many suppliers are active on the India to Thailand Hydroxychloroquine route?
There are currently 7 active Indian suppliers exporting Hydroxychloroquine to Thailand. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 41% of total shipment value.
Q Who are the main importers of Hydroxychloroquine from India in Thailand?
The leading importers of Indian Hydroxychloroquine in Thailand include RANBAXY (THAILAND) CO., LTD. , KASPA PHARMACEUTICAL (THAILAND), KASPA PHARMACEUTICAL THAILAND, RANBAXY (THAILAND) CO., LTD., RANBAXY THAILAND CO LIMITED. RANBAXY (THAILAND) CO., LTD. is the largest buyer with 6 shipments worth $788.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Thailand export trade corridor identified from Indian Customs (DGFT) records for Hydroxychloroquine.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 14 importers in Thailand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 34 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
34 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists